Indivior Pharmaceuticals, Inc.
INDVPharmaceutical Preparations · SIC 2834 · CIK 0001625297
Revenue FY2025
$1.24B
Net Income
$0.21B
EPS (Basic)
$1.68
Net Margin
16.9%
ROE
-214.3%
Total Equity
$(0.10B)
Shares Out
118M
Indivior Pharmaceuticals, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 4 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$189.4M
0.6%
+1.9%
Deerfield Management Company
Deerfield Management Company
$67.7M
0.4%
(46.8%)
Oaktree Capital Management
Howard Marks
$251.4M
0.1%
(12.3%)
Bridgewater Associates
Bridgewater Associates
$2.8M
0.0%
+83.6%
Insider Transactions
Reading stored insider transactions…